Kafa Travmaları (Travmatik Beyin Hasarı)
Özet
Bu metin, Travmatik Beyin Hasarı'nın (TBH) tanımı, epidemiyolojisi, sınıflaması, patofizyolojisi, tanısı ve tedavi yönetimini kapsamlı bir şekilde ele almaktadır. TBH, nöropatolojik hasar ve işlev bozukluğuyla sonuçlanan fiziksel kuvvetler sonucu oluşur ve dünya genelinde önemli bir halk sağlığı sorunudur. En sık nedenleri düşmeler ve motorlu araç kazalarıdır. Sınıflandırma klinik şiddet (Hafif, Orta, Ağır), patoanatomik yapı ve biyomekanik kuvvetlere göre yapılmaktadır. Patofizyolojik süreçte, akselerasyon ve deselerasyon kuvvetleri Diffüz Aksonal Hasarlanmaya (DAI) yol açmakta; mikrotübül bozulmaları ve amiloid öncü protein (APP) birikimi gibi hücresel değişiklikler gözlenmektedir. Tanıda Bilgisayarlı Tomografi (BT) hızlı sonuç verirken, Manyetik Rezonans Görüntüleme (MRG) ve BOS biyobelirteçleri (T-tau, NF-L) aksonal hasarın tespitinde ve prognoz tayininde daha hassastır. Tedavi yönetimi; hastane öncesi, acil servis ve yoğun bakım süreci olarak üçe ayrılır. Temel hedef, birincil hasarın ardından gelişebilecek iskemik-hipoksik hasar ve kafa içi basınç artışı gibi "ikincil hasarları" önlemektir. Yoğun bakımda kafa içi basıncı (İKB) ve serebral perfüzyon basıncının (SPP) dengelenmesi sağkalım ve sekel oranları açısından kritiktir.
This text comprehensively covers the definition, epidemiology, classification, pathophysiology, diagnosis, and treatment management of Traumatic Brain Injury (TBI). TBI results from physical forces causing neuropathological damage and dysfunction, representing a major global public health issue. The most frequent causes are falls and motor vehicle accidents. Classification is based on clinical severity (Mild, Moderate, Severe), pathoanatomical structure, and biomechanical forces. In the pathophysiological process, acceleration and deceleration forces lead to Diffuse Axonal Injury (DAI), involving cellular changes such as microtubule disruption and amyloid precursor protein (APP) accumulation. While Computed Tomography (CT) provides rapid results for diagnosis, Magnetic Resonance Imaging (MRI) and CSF biomarkers (T-tau, NF-L) are more sensitive in detecting axonal damage and determining prognosis. Treatment management is divided into three phases: pre-hospital, emergency department, and intensive care. The primary goal is to prevent "secondary injuries," such as ischemic-hypoxic damage and increased intracranial pressure, which develop following the initial trauma. In intensive care, balancing intracranial pressure (ICP) and cerebral perfusion pressure (CPP) is critical for survival and reducing permanent disability rates.
Referanslar
Ann C Mckee, Daniel H Daneshvar. The neuropathology of traumatic brain injury. Handb Clin Neurol. 2015; 127: 45-66. doi: 10.1016/B978-0-444-52892-6.00004-0.
Tagliaferri F, Compagnone C, Korsic M, Servadei F, Kraus J: A systematic review of brain injury epidemiology in Europe. Acta Neurochir (Wien) 148:255-267, 2006 Mar; 148(3):255-68; discussion 268. doi: 10.1007/s00701-005-0651-y.
Michael A Vella, Marie L Crandall, Mayur B Patel. Acute Management of Traumatic Brain Injury. Surg Clin North Am. 2017 Oct; 97(5):1015-1030. doi: 10.1016/j.suc.2017.06.003.
Kathryn E Saatman, Ann-Christine Duhaime, Ross Bullock, Andrew I R Maas, Alex Valadka, Geoffrey T Manley, Workshop Scientific Team and Advisory Panel Members. Classification of traumatic brain injury for targeted therapies. J Neurotrauma. 2008 Jul;25(7):719-38. doi: 10.1089/neu.2008.0586.
Kaj Blennow, David L Brody, Patrick M Kochanek, Harvey Levin, Ann McKee, Gerard M Ribbers, Kristine Yaffe, Henrik Zetterberg. Traumatic brain injuries. Nat Rev Dis Primers. 2016 Nov 17;2:16084. doi: 10.1038/nrdp.2016.84.
Lee Ann Young, Gregory T Rule, Robert T Bocchieri, Jennie M Burns. Biophysical mechanisms of traumatic brain injuries. Semin Neurol. 2015 Feb;35(1):5-11. doi: 10.1055/s-0035-1544242. Epub 2015 Feb 25.
R J H Cloots, H M T Gervaise, J A W van Dommelen, M G D Geers. Biomechanics of traumatic brain injury: influences of the morphologic heterogeneities of the cerebral cortex. Ann Biomed Eng. 2008 Jul;36(7):1203-15.doi: 10.1007/s10439-008-9510-3.
Ann C McKee, Daniel H Daneshvar, Victor E Alvarez, Thor D Stein. The neuropathology of sport. Acta Neuropathol. 2014 Jan;127(1):29-51. doi: 10.1007/s00401-013-1230-6.
Ann C McKee, Nigel J Cairns, Dennis W Dickson, Rebecca D Folkerth, C Dirk Keene, Irene Litvan, Daniel P Perl, Thor D Stein, Jean-Paul Vonsattel, William Stewart, Yorghos Tripodis, John F Crary, Kevin F Bieniek, Kristen Dams-O'Connor, Victor E Alvarez, Wayne A Gordon, TBI/CTE group. The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy. Acta Neuropathol. 2016 Jan;131(1):75-86. doi: 10.1007/s00401-015-1515-z. Epub 2015 Dec 14.
C W Christman, M S Grady, S A Walker, K L Holloway, J T Povlishock. Ultrastructural studies of diffuse axonal injury in humans. J Neurotrauma. 1994 Apr;11(2):173-86. doi: 10.1089/neu.1994.11.173.
S M Gentleman, M J Nash, C J Sweeting, D I Graham, G W Roberts. Beta-amyloid precursor protein (beta APP) as a marker for axonal injury after head injury. Neurosci Lett. 1993 Oct 1;160(2):139-44.doi: 10.1016/0304-3940(93)90398-5.
John T Povlishock, Douglas I Katz. Update of neuropathology and neurological recovery after traumatic brain injury. J Head Trauma Rehabil. Jan-Feb 2005;20(1):76-94. doi: 10.1097/00001199-200501000-00008.
Kaj Blennow, Mony J de Leon, Henrik Zetterberg. Alzheimer's disease. Lancet. 2006 Jul 29;368(9533):387-403.doi: 10.1016/S0140-6736(06)69113-7.
David J Loane, Alok Kumar, Bogdan A Stoica, Rainier Cabatbat, Alan I Faden. Progressive neurodegeneration after experimental brain trauma: association with chronic microglial activation. J Neuropathol Exp Neurol. 2014 Jan;73(1):14-29. doi:10.1097/NEN.0000000000000021.
Adriano Aguzzi, Ben A Barres, Mariko L Bennett. Microglia: scapegoat, saboteur, or something else? Science. 2013 Jan 11;339(6116):156-61.doi: 10.1126/science.1227901.
Adel Helmy, Keri L H Carpenter, David K Menon, John D Pickard, Peter J A Hutchinson. The cytokine response to human traumatic brain injury: temporal profiles and evidence for cerebral parenchymal production. J Cereb Blood Flow Metab. 2011 Feb;31(2):658-70. doi: 10.1038/jcbfm.2010.142.
Adel Helmy, Mathew R Guilfoyle, Keri L H Carpenter, John D Pickard, David K Menon, Peter J Hutchinson. Recombinant human interleukin-1 receptor antagonist in severe traumatic brain injury: a phase II randomized control trial. J Cereb Blood Flow Metab. 2014 May;34(5):845-51.doi: 10.1038/jcbfm.2014.23.
Jing Ji, Anthony E Kline, Andrew Amoscato, Alejandro K Samhan-Arias, Louis J Sparvero, Vladimir A Tyurin, Yulia Y Tyurina, Bruno Fink, Mioara D Manole, Ava M Puccio, David O Okonkwo, Jeffrey P Cheng, Henry Alexander, Robert S B Clark, Patrick M Kochanek, Peter Wipf, Valerian E Kagan, Hülya Bayır. Lipidomics identifies cardiolipin oxidation as a mitochondrial target for redox therapy of brain injury. Nat Neurosci. 2012 Oct;15(10):1407-13. doi: 10.1038/nn.3195. Epub 2012 Aug 26.
Esther L Yuh, Pratik Mukherjee, Hester F Lingsma, John K Yue, Adam R Ferguson, Wayne A Gordon, Alex B Valadka, David M Schnyer, David O Okonkwo, Andrew I R Maas, Geoffrey T Manley, TRACK-TBI Investigators. Magnetic resonance imaging improves 3-month outcome prediction in mild traumatic brain injury. Ann Neurol. 2013 Feb;73(2):224-35. doi: 10.1002/ana.23783.
David L Brody, Christine L Mac Donald, Joshua S Shimony. Current and future diagnostic tools for traumatic brain injury: CT, conventional MRI, and diffusion tensor imaging. Handb Clin Neurol. 2015;127:267-75. doi: 10.1016/B978-0-444-52892-6.00017-9
Elan J Grossman, Yulin Ge, Jens H Jensen, James S Babb, Laura Miles, Joseph Reaume, Jonathan M Silver, Robert I Grossman, Matilde Inglese. Thalamus and cognitive impairment in mild traumatic brain injury: a diffusional kurtosis imaging study. J Neurotrauma. 2012 Sep;29(13):2318-27. doi: 10.1089/neu.2011.1763.
Rajendra A Morey, Courtney C Haswell, Elizabeth S Selgrade, Dino Massoglia, Chunlei Liu, Jonathan Weiner, Christine E Marx, MIRECC Work Group; Ibolja Cernak, Gregory McCarthy. Effects of chronic mild traumatic brain injury on white matter integrity in Iraq and Afghanistan war veterans. Hum Brain Mapp. 2013 Nov;34(11):2986-99. doi: 10.1002/hbm.22117.
Nora Presson, Sue R Beers, Lisa Morrow, Lauren M Wagener, William A Bird, Gina Van Eman, Deepa Krishnaswamy, Joshua Penderville, Allison J Borrasso, Steven Benso, Ava Puccio, Catherine Fissell, David O Okonkwo, Walter Schneider. An exploratory analysis linking neuropsychological testing to quantification of tractography using High Definition Fiber Tracking (HDFT) in military TBI. Brain Imaging Behav. 2015 Sep;9(3):484-99. doi: 10.1007/s11682-015-9386-4.
Xiaojie Wang, Matthew F Cusick, Yong Wang, Peng Sun, Jane E Libbey, Kathryn Trinkaus, Robert S Fujinami, Sheng-Kwei Song. Diffusion basis spectrum imaging detects and distinguishes coexisting subclinical inflammation, demyelination and axonal injury in experimental autoimmune encephalomyelitis mice. NMR Biomed. 2014 Jul;27(7):843-52. doi: 10.1002/nbm.3129.
Henrik Zetterberg, Douglas H Smith, Kaj Blennow. Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood. Nat Rev Neurol. 2013 Apr;9(4):201-10. doi: 10.1038/nrneurol.2013.9.
M Ost, K Nylén, L Csajbok, A Olsson Ohrfelt, M Tullberg, C Wikkelsö, P Nellgård, L Rosengren, K Blennow, B Nellgård. Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury. Neurology. 2006 Nov 14;67(9):1600-4. doi: 10.1212/01.wnl.0000242732.06714.0f.
Jonathan Marehbian, Susanne Muehlschlegel, Brian L Edlow, Holly E Hinson, David Y Hwang. Medical Management of the Severe Traumatic Brain Injury Patient. Neurocrit Care. 2017 Dec;27(3):430-446.doi: 10.1007/s12028-017-0408-5.
